SPONSOR
Queen Mary University of London
Total Trials
9
Recruiting
9
Phases
Phase 1, Phase 2
Conditions studied: Acute Respiratory Failure (ARF)Non Invasive VentilationRelapsing Remitting Multiple SclerosisPrimary Progressive Multiple SclerosisSecondary Progressive Multiple SclerosisParkinson's Disease and ParkinsonismProgressive Supranuclear PalsyDifferent Types of Tremor Including Essential TremorDystoniaMultiple System Atrophy
Queen Mary University of London is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Acute Respiratory Failure (ARF), Non Invasive Ventilation, Relapsing Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Queen Mary University of London
How many clinical trials has Queen Mary University of London sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by Queen Mary University of London, of which 9 are actively recruiting participants. These trials cover conditions including Acute Respiratory Failure (ARF), Non Invasive Ventilation, Relapsing Remitting Multiple Sclerosis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Queen Mary University of London research focus on?
Queen Mary University of London clinical trials span Acute Respiratory Failure (ARF), Non Invasive Ventilation, Relapsing Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Queen Mary University of London clinical trial?
To participate in a Queen Mary University of London trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Queen Mary University of London trials with current recruitment status updated daily.
Clinical Trials by Queen Mary University of London
NCT07423338
Recruiting
Monitoring Respiratory Muscle Function in Acute Respiratory Failure Patients on Non Invasive Respiratory Support
Acute Respiratory Failure (ARF)
NCT03783416 Phase 1
Recruiting
SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis
Relapsing Remitting Multiple Sclerosis
NCT06174948
Recruiting
The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders
Parkinson's Disease and Parkinsonism
NCT06700018
Recruiting
Flow Patterns and Stent Thrombosis
Stent Thrombosis
NCT06602336
Recruiting
A Single Centre Study Comparing Continuous Interstitial Fluid Lactate Detection to Standard Measurements of Lactate in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery and/or Valve Replacement.
Coronary Artery Bypass
NCT06309719
Recruiting
Hyaluronic Acid and Polynucleotides for Supra-bony Defects
Periodontal Diseases
NCT04330599
Recruiting
Longitudinal Population-based Observational Study of COVID-19 in the UK Population
COVID-19
NCT07035691
Recruiting
New bioMarkers tO straTIfy cOlorectal caNcer Referrals
Colorectal Carcinoma
NCT04624399 Phase 2
Recruiting
Neoadjuvant Immune Checkpoint Inhibitor Treatment in Urothelial Cancer
Urogenital Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology